Dixie Fox, DPM
Foot & Ankle Surgery · Rolla, MONPI 1669792099
Payments from drug & device makers
Across 51 payments — averaging $30.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$833
- Organogenesis Inc.$248
- Smith+Nephew$51
- Bioventus LLC$44
- Misonix Inc$41
- Elite Orthopedics, LLC$40
- plus $283 from 12 others
What the payments were for
- Food & beverage$1,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 17 | $833 |
| Organogenesis Inc. | 8 | $248 |
| Smith+Nephew | 3 | $51 |
| Bioventus LLC | 2 | $44 |
| Misonix Inc | 3 | $41 |
| Elite Orthopedics, LLC | 2 | $40 |
| Treace Medical Concepts, Inc. | 2 | $38 |
| Integra Lifesciences Corporation | 2 | $38 |
| Celularity Inc. | 2 | $33 |
| AbbVie | 1 | $30 |
| Checkpoint Surgical, Inc | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Axogen | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$165
- ANCHORAGE$145
- BIOskin$105
How this compares
$1,541 in reported general payments places this provider in the 25th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 31 | $758 |
| Gentamicin Sulfate | 16 | $641 |
| Pregabalin | 16 | $441 |
| Gabapentin | 24 | $393 |
| Betamethasone Dipropionate | 12 | $332 |
| Cephalexin | 67 | $314 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $293 |
| Ibuprofen | 22 | $252 |
| Clindamycin Hcl | 15 | $129 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Rolla
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Amar PatelLees Summit$272K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.